the treatment of prostatic carcinoma with diethylstilboestrol ( des ) and ethinyloestradiol ( lynoral ) has become less popular since the introduction of new forms of treatment such as antiandrogens , estramustine phosphate and lhrh analogues .
C0015011
ethinyloestradiol
C0699367
lynoral